ZA882107B - Morpholine derivatives,the process for their preparation and the pharmaceutical compositions containing them - Google Patents

Morpholine derivatives,the process for their preparation and the pharmaceutical compositions containing them

Info

Publication number
ZA882107B
ZA882107B ZA882107A ZA882107A ZA882107B ZA 882107 B ZA882107 B ZA 882107B ZA 882107 A ZA882107 A ZA 882107A ZA 882107 A ZA882107 A ZA 882107A ZA 882107 B ZA882107 B ZA 882107B
Authority
ZA
South Africa
Prior art keywords
preparation
pharmaceutical compositions
compositions containing
morpholine derivatives
aralkyl
Prior art date
Application number
ZA882107A
Other languages
English (en)
Inventor
Gilbert Regnier
Regnier Gilbert
Claude Guillonneau
Guillonneau Claude
Jean Lepagnol
Lepagnol Jean
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of ZA882107B publication Critical patent/ZA882107B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Control For Baths (AREA)
  • Earth Drilling (AREA)
ZA882107A 1987-03-24 1988-03-24 Morpholine derivatives,the process for their preparation and the pharmaceutical compositions containing them ZA882107B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8704047A FR2612926B1 (fr) 1987-03-24 1987-03-24 Nouveaux derives de la morpholine, leur procede de preparation et les compositions pharmaceutiques les renfermant

Publications (1)

Publication Number Publication Date
ZA882107B true ZA882107B (en) 1989-06-28

Family

ID=9349348

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA882107A ZA882107B (en) 1987-03-24 1988-03-24 Morpholine derivatives,the process for their preparation and the pharmaceutical compositions containing them

Country Status (17)

Country Link
US (1) US4782054A (xx)
EP (1) EP0286495B1 (xx)
JP (1) JPH0657709B2 (xx)
AT (1) ATE89281T1 (xx)
AU (1) AU600209B2 (xx)
CA (1) CA1313870C (xx)
DE (1) DE3880874T2 (xx)
DK (1) DK171580B1 (xx)
ES (1) ES2006390A6 (xx)
FR (1) FR2612926B1 (xx)
GR (1) GR1000241B (xx)
HK (1) HK57297A (xx)
IE (1) IE61882B1 (xx)
NZ (1) NZ223984A (xx)
OA (1) OA08822A (xx)
PT (1) PT87061B (xx)
ZA (1) ZA882107B (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2653999A1 (fr) * 1989-11-06 1991-05-10 Adir Nouveaux derives de la morpholine, leur procede de preparation et les compositions pharmaceutiques les renfermant.
US5637699A (en) * 1992-06-29 1997-06-10 Merck & Co., Inc. Process for preparing morpholine tachykinin receptor antagonists
US5719147A (en) * 1992-06-29 1998-02-17 Merck & Co., Inc. Morpholine and thiomorpholine tachykinin receptor antagonists
US6048859A (en) * 1992-06-29 2000-04-11 Merck & Co., Inc. Morpholine and thiomorpholine tachykinin receptor antagonists
TW385308B (en) * 1994-03-04 2000-03-21 Merck & Co Inc Prodrugs of morpholine tachykinin receptor antagonists
AU2005238296A1 (en) * 2004-04-30 2005-11-10 Warner-Lambert Company Llc Substituted morpholine compounds for the treatment of central nervous system disorders
GB0409744D0 (en) * 2004-04-30 2004-06-09 Pfizer Ltd Novel compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1138405A (en) * 1966-12-28 1969-01-01 Ici Ltd Morpholine derivatives
BE758766A (fr) * 1969-11-17 1971-05-10 Ici Ltd Nouveaux derives de la morpholine et de la

Also Published As

Publication number Publication date
CA1313870C (fr) 1993-02-23
NZ223984A (en) 1990-05-28
DE3880874D1 (de) 1993-06-17
PT87061B (pt) 1992-07-31
FR2612926B1 (fr) 1989-06-09
JPS63255279A (ja) 1988-10-21
PT87061A (pt) 1988-04-01
DK150088D0 (da) 1988-03-18
DE3880874T2 (de) 1993-12-23
IE61882B1 (en) 1994-11-30
AU600209B2 (en) 1990-08-02
AU1352088A (en) 1988-09-22
HK57297A (en) 1997-05-09
EP0286495B1 (fr) 1993-05-12
GR880100179A (en) 1989-01-31
ATE89281T1 (de) 1993-05-15
US4782054A (en) 1988-11-01
IE880851L (en) 1988-09-24
ES2006390A6 (es) 1989-04-16
EP0286495A1 (fr) 1988-10-12
DK171580B1 (da) 1997-02-03
OA08822A (fr) 1989-03-31
JPH0657709B2 (ja) 1994-08-03
FR2612926A1 (fr) 1988-09-30
GR1000241B (el) 1992-05-12
DK150088A (da) 1988-09-25

Similar Documents

Publication Publication Date Title
PT80661B (en) Process for preparing substituted imidazopyridines
ES8604565A1 (es) Un derivado de acido 6-fluor-1, 4-dihidro-4-oxo-7-piperazinil-quinolin sustituido-3-carboxilico
ZA882107B (en) Morpholine derivatives,the process for their preparation and the pharmaceutical compositions containing them
DE3063288D1 (en) Paromomycin derivatives, a process for the preparation thereof and therapeutical composition containing them
HU901570D0 (en) Process for the preparation of azetidinyl-pyridonecarboxylic acid derivatives and pharmaceutical compositions containing such compounds
AU610173B2 (en) New spiro (4,5) decane derivatives, process for the preparation thereof, and pharmaceutical compositions containing them
HUT48464A (en) Process for producing pharmaceutical composition for treating hypertonia and cardiac failure
AU631465B2 (en) New morpholine derivatives, the process for the preparation thereof and the pharmaceutical compositions containing them
CA2119661A1 (fr) Nouveaux composes de n-benzylpiperazine, leur procede de preparation et les compositions pharmaceutiques les renfermant
IL86169A (en) Substituted quinoxalyl-imidazolidine-2,4-diones,processes for their preparation and pharmaceutical compositions containing them
AU5608790A (en) New pyrrolidone derivatives, the process for their preparation and the pharmaceutical compositions containing them
IL85231A0 (en) Substituted 3-phenyl-7h-thiazolo(3,2-b)(1,2,4)triazin-7-ones,a process for the preparation thereof,pharmaceutical compositions containing same and the use thereof
IL85229A0 (en) Novel imidazo-and triazolothiadiazines,a process for the preparation thereof,pharmaceutical compositions containing same,and the use thereof
DE3680893D1 (de) Pyrimido(5,4-b)(1,4)oxazinderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel sowie zwischenprodukte darstellende pyrimido(5,4-b)(1,4)oxazinderivate.
ZA948515B (en) Cyclised analogues of fatty acid metabolites,a process for their preparation and pharmaceutical compositions containing them
FR2592653A1 (fr) Derives de chromene, procede d'obtention et compositions pharmaceutiques.
HUT34158A (en) Process for preparing 2-alkyl-mercapto-1-amino-alkyl-2-pyrroline-3-carbonitriles